Ip TP, et al.; OSHK. Hong Kong Med J. 2013 Apr;19 Suppl 2:1-40
The Osteoporosis Society Of Hong Kong: Do You Know? Available at: https://oshk.org.hk/. Accessed on: 28 Nov 2025.
Cosman F, et al.; National Osteoporosis Foundation. Osteoporos Int. 2014;25:2359-2381
Alexandru D, So W. Perm J. 2012_16 46-51
Leung KS, Yuen WF, et al. Hong Kong Med J. Epub 2017 May 5. Doi: 10.12809/hkmj166214
Carpintero P et al. World J Orthop. 2014_5_402-411.
Kim, Chul-Ho, Keunho Kim, and Ji Wan Kim. "The effect of denosumab on minimum 3-years BMD changes in patients with osteoporotic hip fractures: a propensity score matching analysis." Osteoporosis International 36.2 (2025): 265-274.
Furukawa, Karin, et al. "Long-term effectiveness and safety of denosumab for osteoporosis in patients with rheumatic diseases." The Journal of Rheumatology (2025).
Wong, Ronald Man Yeung, et al. "Recommendations on the post-acute management of the osteoporotic fracture-Patients with “very-high” Re-fracture risk." Journal of Orthopaedic Translation 37 (2022): 94-99.